Hot News
RNS: AstraZeneca has admitted in court documents that its COVID-19 vaccine, developed with the University of Oxford, can lead to a rare side effect known as thrombosis with thrombocytopenia syndrome …
AstraZeneca admits COVID-19 vaccine can cause rare side effects Read More
Book Review Author: Ashis Sinha The COVID-19 pandemic will undoubtedly be remembered as one of the most transformative events in modern history. In “Lesson We Learned from the COVID-19 Pandemic,” …
“Lesson We Learned from the COVID-19 Pandemic” Read More
New Delhi: The World Health Organization (WHO) has given its endorsement to a cost-effective and highly efficient malaria vaccine developed through collaboration between the Pune-based Serum Institute of India (SII) …
WHO approves world’s 2nd malaria vaccine; cheaper & easier to produce Read More
RNS: iNCOVACC— nasal vaccine against Covid-19 would be available in the market for the public from the fourth week of January. Bharat Biotech, Hyderabad-based Biotechnology Company said that the vaccine …
iNCOVACC @ Rs 800 from January 23 Read More
RNS: The intranasal Covid-19 vaccine— iNCOVACC (BBV154), developed by Bharat Biotech, received approval from the ministry of health on Friday to be added to the vaccination programme as a booster …
iNCOVACC – Nasal spray vaccine gets Govt. nod as booster shot in adults Read More
RNS: World’s first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situations in the age …
World’s first COVID intra-nasal vaccine gets CDSCO approval for restricted use Read More
RNS: WHO warns of an urgent threat of measles spreading globally due to COVID-19’s drop in vaccination coverage and poor disease surveillance. Nearly 40 million children missed a measles vaccine …
Around 40 million kids skipped measles vaccine last year due to COVID pandemic: WHO Read More
RNS: Government has decided to make precaution doses of COVID vaccines available to the above 18 population group from tomorrow at private vaccination centres. “All those who are more than …
COVID precaution dose for all above 18 years Read More
RNS: Amidst rising COVID cases in European and few Asian countries, the National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap between the first and second dose …
“Reduce Covishield vaccine gap” : NTAGI Read More
RNS: Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation to COVID-19 vaccine Corbevax for children between 12-18 years of age group. With the emergency use approval to …
DCGI grants EUA to Corbevax for children between 12-18 years Read More